Minerva Surgical, Inc. (UTRS)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 29, 2026

Minerva Surgical Company Description

Minerva Surgical, Inc. provides a suite of devices to treat the root causes of abnormal uterine bleeding in the United States.

The company provides Minerva Endometrial Ablation System, a technology that uses three methods of tissue ablation; Symphion System that is designed for fluid management, direct intrauterine pressure monitoring, and bladeless resection work; and Genesys HTA, an endometrial ablation device for the treatment of a wider range of uterine cavities.

It also offers Resectr, a tissue resection device to diagnose and treat polyps; and HERizon electronic disposable hysteroscope, image processor, Hysto-Kit, and endoscopic accessories that helps gynecologists to evaluate abnormal uterine bleeding and provide care.

The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Minerva Surgical, Inc.
CountryUnited States
Founded2008
IndustryMedical Devices
SectorHealthcare
Employees174
CEODarin Hammers

Contact Details

Address:
4255 Burton Drive
Santa Clara, California 95054
United States
Phone855 646 7874
Websiteminervasurgical.com

Stock Details

Ticker SymbolUTRS
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS60343F1066
SIC Code3841

Key Executives

NamePosition
Darin HammersChief Executive Officer
Greg SimbroVice President of Finance
Wendy BowmanVice President of Human Resources
Dr. Evgueni V. Skalnyi M.D.Chief Medical Officer
Brent PalmisanoChief Commercial Officer
Joanne LongVice President of Corporate Controller